Perceptron, Inc. (NASDAQ:PRCP), a leading global
provider of 3D automated metrology solutions and coordinate
measuring machines, today announced results for the second quarter
of its 2018 fiscal year (quarterly period ended December 31,
2017).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL HIGHLIGHTS (in millions, except per
share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
|
|
2017 |
|
2016 |
|
Change |
|
2017 |
|
2016 |
|
Change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
$ |
20.4 |
|
$ |
21.8 |
|
$ |
(1.4 |
) |
|
$ |
39.7 |
|
$ |
39.3 |
|
$ |
0.4 |
Net
Income |
|
|
|
0.4 |
|
|
2.5 |
|
|
(2.1 |
) |
|
|
1.9 |
|
|
0.1 |
|
|
1.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
Income per Share |
|
$ |
0.04 |
|
$ |
0.27 |
|
$ |
(0.23 |
) |
|
$ |
0.20 |
|
$ |
0.02 |
|
$ |
0.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Second quarter fiscal 2018 results compared to second quarter
fiscal 2017:
- Second quarter consolidated net sales were $20.4 million, a
decrease of 6.4% as compared to a strong second quarter in fiscal
year 2017
- Consolidated gross profit was $7.4 million and gross margin was
36.3%
- Second quarter and year-to-date results include a charge of
$0.7 million for a court award in a trade secrets case granting
defendants’ motions for the recovery of attorney fees
- Second quarter reported operating income totaled $0.5 million
and recurring operating income of $1.1 million
- Net income for the second quarter of fiscal 2018 was $0.4
million
- Second quarter diluted earnings per share was $0.04 per diluted
share
- Bookings were $20.0 million; bookings have been at least $20
million for six out of the last seven quarters
- Backlog increased 16.3% to $48.5 million, a record for the
Company’s second quarter
- Cash and short-term investments totaled $9.0 million for the
period ending December 31, 2017
Year-to-date fiscal 2018 results compared to year-to-date fiscal
2017:
- Year-to-date consolidated net sales increased 1.0% to $39.7
million
- Year-to-date consolidated gross profit increased $1.1 million
to $15.1 million
- Consolidated gross margin was 38.0%, an increase of 240 basis
points
- Year-to-date reported operating income totaled $2.0 million and
recurring operating income was $2.6 million
- Net income increased considerably, growing by $1.8 million to
$1.9 million for year-to-date fiscal 2018
- Year-to-date diluted earnings per share also improved
significantly, achieving $0.20 as compared to $0.02 per share in
the prior year-to-date period
- Bookings increased 1.2% to $43.2 million for year-to-date
fiscal 2018
Third quarter and full year 2018 guidance:
- Expect revenue in the range of $18.0 million to $21.0
million
- Reaffirm our previous guidance of mid-single digit revenue
growth for fiscal year 2018
David Watza, President and CEO, commented, “We
are pleased with the progress we continue to make this fiscal year,
as we were able to achieve recurring operating income in excess of
$1.0 million for the third consecutive quarter, excluding the $0.7
million charge related to a court award in a trade secrets case,
which we plan to appeal. Year-to-date bookings and backlog remain
strong, while revenue grew slightly. Our elevated backlog levels
mark a second quarter record for the Company.”
“We remain well positioned this fiscal year with
an increase of 54% in our year-to-date reported operating income,
while we also generated strong operating cash flows of $4.0 million
so far in fiscal 2018,” added Watza. “The strategic plan we
put into place continues to drive strength in key customer demand
metrics, as evidenced by the robust backlog this quarter. We are
confident that a relentless focus in our core markets will continue
to provide sustainable and profitable long-term growth
opportunities as we continue to remove cost from our system and
deliver more value to our customers.”
“Finally, and most importantly, when I look at
our development initiatives, we made several significant steps
during the quarter,” continued Watza. “We launched our
Helix®evo product line in October and delivered several systems
with this product during our fiscal second quarter. The
Helix®evo product is our most advanced 3D scanning sensor and we
are very excited about its potential, based on customer
feedback. In addition, we demonstrated our AccuSite™ product
line at the Quality Show in Chicago with several customer
deliveries expected during our current fiscal year. AccuSite™
is our next evolution in accurate measurement. Perceptron pioneered
Absolute Accuracy for robotic measurement systems in 2005. Our
AccuSite™ solution provides best-in-class system accuracy and
eliminates the need to offset to a CMM. This capability
dramatically increases the applications available in the
marketplace.”
“Looking ahead to our third quarter of fiscal
year 2018, we expect revenue in the range of $18.0 million to $21.0
million, and affirm our previous guidance of mid-single digit
growth in our top line results for the full year fiscal 2018.
Our longer-term aspirations are for sustained high-single digit
revenue growth and resulting double-digit earnings growth,” Watza
concluded.
Highlights of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME STATEMENT KEY METRICS
(in millions, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
|
|
|
|
2017 |
|
2016 |
|
Change |
|
2017 |
|
2016 |
|
Change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas Sales |
|
|
$ |
10.0 |
|
|
$ |
9.1 |
|
|
$ |
0.9 |
|
|
$ |
18.0 |
|
|
$ |
14.3 |
|
|
$ |
3.7 |
|
|
Europe Sales |
|
|
|
6.4 |
|
|
|
7.7 |
|
|
|
(1.3 |
) |
|
|
14.2 |
|
|
|
17.7 |
|
|
|
(3.5 |
) |
|
Asia Sales |
|
|
|
4.0 |
|
|
|
5.0 |
|
|
|
(1.0 |
) |
|
|
7.5 |
|
|
|
7.3 |
|
|
|
0.2 |
|
Total Sales |
|
|
$ |
20.4 |
|
|
$ |
21.8 |
|
|
$ |
(1.4 |
) |
|
$ |
39.7 |
|
|
$ |
39.3 |
|
|
$ |
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit |
|
|
$ |
7.4 |
|
|
$ |
9.4 |
|
|
$ |
(2.0 |
) |
|
$ |
15.1 |
|
|
$ |
14.0 |
|
|
$ |
1.1 |
|
|
Gross Profit as a percent of sales |
|
|
36.3 |
% |
|
|
43.1 |
% |
|
|
|
|
38.0 |
% |
|
|
35.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income |
|
|
$ |
0.5 |
|
|
$ |
3.3 |
|
|
$ |
(2.8 |
) |
|
$ |
2.0 |
|
|
$ |
1.3 |
|
|
$ |
0.7 |
|
|
Operating Income as a percent of sales |
|
|
2.5 |
% |
|
|
15.1 |
% |
|
|
|
|
5.0 |
% |
|
|
3.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income |
|
|
$ |
0.4 |
|
|
$ |
2.5 |
|
|
$ |
(2.1 |
) |
|
$ |
1.9 |
|
|
$ |
0.1 |
|
|
$ |
1.8 |
|
Diluted Income per Share |
|
$ |
0.04 |
|
|
$ |
0.27 |
|
|
$ |
(0.23 |
) |
|
$ |
0.20 |
|
|
$ |
0.02 |
|
|
$ |
0.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recurring Operating Income |
|
$ |
1.1 |
|
|
$ |
3.4 |
|
|
$ |
(2.3 |
) |
|
$ |
2.6 |
|
|
$ |
2.1 |
|
|
$ |
0.5 |
|
|
Recurring Operating Income as a percent of sales |
|
5.4 |
% |
|
|
15.6 |
% |
|
|
|
|
6.5 |
% |
|
|
5.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total sales for the second quarter of fiscal
2018 decreased $1.4 million, or 6.4%, versus the same quarter in
the prior year, reflecting decreases in Europe and Asia
regions. The Europe region was down due to decreases in
In-Line and Near-Line Measurement Solutions, partially offset by
small increases in Off-Line Measurement Solutions and Value-Added
Services. The decline in the Asia region was primarily due to
decreases in the In-Line and Near-Line Measurement Solutions as
well as the 3D Scanning Solutions, partially offset by an increase
in sales of Off-Line Measurement Solutions. The
year-over-year improvement in the Americas region was primarily due
to increases in In-Line and Near-Line Measurement Solutions and
Value-Added Services, partially offset by decreased sales of 3D
Scanning Solutions.
In the second quarter of fiscal 2018, gross
profit as a percentage of sales declined by 680 basis points
compared to the prior year period, primarily due to the lower
volume of sales, the mix of the Company’s revenue, the timing of
certain expenses in cost of goods sold under applicable accounting
rules and higher warranty costs.
During the second quarter of fiscal 2018, our
SG&A, Engineering and R&D expenses were up $0.3 million,
primarily as a result of strategic investments in several
engineering, research and development initiatives as well as
increased legal and audit fees and an increase in Board of Director
fees, partially offset by lower bad debt expense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
BOOKINGS (in millions) |
|
2017 |
|
2016 |
|
Change |
|
2017 |
|
|
2016 |
|
Change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic Region |
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas |
|
|
$ |
6.9 |
|
$ |
8.5 |
|
$ |
(1.6 |
) |
|
$ |
16.5 |
|
$ |
19.3 |
|
$ |
(2.8 |
) |
|
Europe |
|
|
|
8.0 |
|
|
8.6 |
|
|
(0.6 |
) |
|
|
17.4 |
|
|
14.8 |
|
|
2.6 |
|
|
Asia |
|
|
|
5.1 |
|
|
3.8 |
|
|
1.3 |
|
|
|
9.3 |
|
|
8.6 |
|
|
0.7 |
|
Total Bookings |
|
|
$ |
20.0 |
|
$ |
20.9 |
|
$ |
(0.9 |
) |
|
$ |
43.2 |
|
$ |
42.7 |
|
$ |
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BACKLOG (in millions) |
|
12/31/2017 |
|
9/30/2017 |
|
6/30/2017 |
|
3/31/2017 |
|
12/31/2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic Region |
|
|
|
|
|
|
|
|
|
|
|
Americas |
|
|
$ |
18.0 |
|
$ |
21.1 |
|
$ |
19.5 |
|
$ |
20.9 |
|
$ |
15.6 |
|
Europe |
|
|
|
19.6 |
|
|
18.0 |
|
|
16.4 |
|
|
16.7 |
|
|
16.2 |
|
Asia |
|
|
|
10.9 |
|
|
9.8 |
|
|
9.1 |
|
|
11.0 |
|
|
9.9 |
Total Backlog |
|
|
$ |
48.5 |
|
$ |
48.9 |
|
$ |
45.0 |
|
$ |
48.6 |
|
$ |
41.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Second quarter bookings were $20.0 million. The
decrease in booking activity is primarily due to decreases in 3D
Scanning Solutions and Value Added Services, partially offset by
increases in Off-Line Measurement Solutions and In-Line and
Near-Line Measurement Solutions. The significant booking
activity in Asia was driven by increases in In-Line and Near-Line
Measurement Solutions and Off-Line Measurement Solutions, partially
offset by a decrease in 3D Scanning Solutions.
Revenue in the second quarter of fiscal 2018
exceeded bookings by $0.4 million, which resulted in a decrease in
backlog to $48.5 million at December 31, 2017. This is the
highest backlog level for a second quarter in the Company’s
history. As the levels of bookings and backlog typically fluctuate
from quarter to quarter, management does not necessarily consider
these metrics to be indicative of the future operating performance
of the Company.
FINANCIAL POSITION
Cash and short-term investment balance was $ 9.0
million at December 31, 2017, up from $8.1 million at September 30,
2017 and up from $6.3 million at December 31, 2016. At
December 31, 2017, bank debt outstanding totaled $1.6 million, up
from an outstanding balance of $0.4 million at September 30, 2017
and up from $1.4 million at December 31, 2016.
Quarterly Investor Call and
Webcast
Perceptron, Inc., will hold its second quarter
fiscal year 2018 investor conference call/webcast, chaired by David
L. Watza, President and CEO, on Tuesday, February 6, 2018, at 10:00
AM (EST). Investors can access the call at:
Webcast |
|
|
investors.perceptron.com on the Event page |
Conference Call |
|
|
877-317-6789 (domestic callers) or
|
|
|
|
412-317-6789 (international callers) |
Conference ID |
|
|
10115732 |
A replay will be posted to the Company's website
after the conference call concludes.
About Perceptron®
Perceptron (NASDAQ:PRCP) develops, produces and
sells a comprehensive range of automated industrial metrology
products and solutions to manufacturing organizations for
dimensional gauging, dimensional inspection and 3D scanning.
Products include 3D machine vision solutions, robot guidance,
coordinate measuring machines, laser scanning and advanced analysis
software. Global automotive, aerospace and other manufacturing
companies rely on Perceptron's metrology solutions to assist in
managing their complex manufacturing processes to improve quality,
shorten product launch times and reduce costs. Headquartered in
Plymouth, Michigan, USA, Perceptron has subsidiary operations in
Brazil, China, Czech Republic, France, Germany, India, Italy,
Japan, Singapore, Slovakia, Spain and the United Kingdom. For
more information, please visit www.perceptron.com.
Safe Harbor Statement
Certain statements in this press release may be
“forward-looking statements” within the meaning of the Securities
Exchange Act of 1934, including our expectation as to our fiscal
year 2018 and future results, operating data, new order bookings,
revenue, expenses, net income and backlog levels, trends affecting
our future revenue levels, the rate of new orders, the timing of
revenue and net income increases from new products which we have
recently released or have not yet released, the timing of the
introduction of new products, and our ability to fund our fiscal
year 2018 and future cash flow requirements. Whenever
possible, we have identified these forward-looking statements by
words such as “target,” “will,” “should,” “could,” “believes,”
“expects,” “anticipates,” “estimates,” “prospects,” “outlook,”
“guidance” or similar expressions. We claim the protection of
the safe harbor for forward-looking statements contained in the
Private Securities Litigation Reform Act of 1995 for all of our
forward-looking statements. While we believe that our
forward-looking statements are reasonable, you should not place
undue reliance on any such forward-looking statements, which speak
only as of the date made. Because these forward-looking
statements are based on estimates and assumptions that are subject
to significant business, economic and competitive uncertainties,
many of which are beyond our control or are subject to change,
actual results could be materially different. Factors that
might cause such a difference include, without limitation, the
risks and uncertainties discussed from time to time in our periodic
reports filed with the Securities and Exchange Commission,
including those listed in “Item 1A – Risk Factors” of our Annual
Report on Form 10-K for fiscal 2017. Except as required by
applicable law, we do not undertake, and expressly disclaim, any
obligation to publicly update or alter our statements whether as a
result of new information, events or circumstances occurring after
the date of this report or otherwise.
--- Financial Tables Follow ---
|
|
|
|
|
|
|
|
|
|
|
|
PERCEPTRON, INC. |
SELECTED FINANCIAL DATA |
(Unaudited, In Thousands Except Per Share
Amounts) |
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Income Statements |
|
|
Three Months Ended |
|
Six Months Ended |
|
|
|
|
|
December 31, |
|
December 31, |
|
|
|
|
|
2017 |
|
2016 |
|
2017 |
|
2016 |
Net
Sales |
|
|
$ |
20,433 |
|
|
$ |
21,751 |
|
|
$ |
39,702 |
|
|
$ |
39,271 |
|
Cost of Sales |
|
|
|
13,026 |
|
|
|
12,307 |
|
|
|
24,645 |
|
|
|
25,253 |
|
|
Gross Profit |
|
|
|
7,407 |
|
|
|
9,444 |
|
|
|
15,057 |
|
|
|
14,018 |
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
Selling,
General and Administrative Expense |
|
|
4,497 |
|
|
|
4,469 |
|
|
|
8,921 |
|
|
|
8,756 |
|
Engineering, Research and Development Expense |
|
|
1,797 |
|
|
|
1,657 |
|
|
|
3,530 |
|
|
|
3,267 |
|
Severance,
Impairment and Other Charges |
|
|
658 |
|
|
|
61 |
|
|
|
606 |
|
|
|
717 |
|
|
Operating Income |
|
|
|
455 |
|
|
|
3,257 |
|
|
|
2,000 |
|
|
|
1,278 |
|
Other Income and (Expenses), net |
|
|
|
|
|
|
|
|
|
Interest
Expense, net |
|
|
|
(42 |
) |
|
|
(61 |
) |
|
|
(84 |
) |
|
|
(118 |
) |
Foreign
Currency and Other, net |
|
|
|
(62 |
) |
|
|
(370 |
) |
|
|
(54 |
) |
|
|
(320 |
) |
Income Before Income Taxes |
|
|
|
351 |
|
|
|
2,826 |
|
|
|
1,862 |
|
|
|
840 |
|
Income Tax Benefit (Expense) |
|
|
|
15 |
|
|
|
(302 |
) |
|
|
62 |
|
|
|
(671 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income |
|
|
$ |
366 |
|
|
$ |
2,524 |
|
|
$ |
1,924 |
|
|
$ |
169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Per Common Share |
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
$ |
0.04 |
|
|
$ |
0.27 |
|
|
$ |
0.20 |
|
|
$ |
0.02 |
|
|
Diluted |
|
|
$ |
0.04 |
|
|
$ |
0.27 |
|
|
$ |
0.20 |
|
|
$ |
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Common Shares Outstanding |
|
|
|
|
|
|
|
|
Basic |
|
|
|
9,491 |
|
|
|
9,381 |
|
|
|
9,455 |
|
|
|
9,376 |
|
|
Diluted |
|
|
|
9,597 |
|
|
|
9,416 |
|
|
|
9,527 |
|
|
|
9,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PERCEPTRON, INC. |
SELECTED FINANCIAL DATA |
(In Thousands) |
|
|
|
|
|
|
|
|
Condensed Balance Sheets |
|
|
December 31, |
|
June 30, |
|
|
|
|
|
2017 |
|
2017 |
|
|
|
|
|
(Unaudited) |
|
|
Cash and
Cash Equivalents |
|
|
$ |
6,346 |
|
$ |
3,704 |
Short-Term
Investments |
|
|
|
2,639 |
|
|
1,572 |
Receivables, net |
|
|
|
|
27,909 |
|
|
31,943 |
Inventories, net |
|
|
|
|
15,320 |
|
|
11,466 |
Other
Current Assets |
|
|
|
1,736 |
|
|
1,953 |
Total Current Assets |
|
|
|
53,950 |
|
|
50,638 |
|
|
|
|
|
|
|
|
Property
and Equipment, net |
|
|
|
7,365 |
|
|
7,377 |
Goodwill
and Other Intangible Assets, net |
|
|
11,938 |
|
|
11,866 |
Long-Term
Deferred Income Tax Asset |
|
|
919 |
|
|
9 |
Long-Term
Investments |
|
|
|
725 |
|
|
725 |
Total Non-Current Assets |
|
|
|
20,947 |
|
|
19,977 |
|
|
|
|
|
|
|
|
Total Assets |
|
|
$ |
74,897 |
|
$ |
70,615 |
|
|
|
|
|
|
|
|
Line of
Credit and Short-Term Notes Payable |
|
$ |
1,821 |
|
$ |
1,705 |
Accounts
Payable |
|
|
|
9,209 |
|
|
8,280 |
Deferred
Revenue |
|
|
|
8,679 |
|
|
8,485 |
Restructuring Reserve |
|
|
|
1,244 |
|
|
1,113 |
Other
Current Liabilities |
|
|
|
7,022 |
|
|
8,572 |
Total Current Liabilities |
|
|
|
27,975 |
|
|
28,155 |
|
|
|
|
|
|
|
|
Long-Term
Taxes Payable |
|
|
|
719 |
|
|
969 |
Long-Term
Deferred Income Tax Liability |
|
|
1,709 |
|
|
871 |
Other
Long-Term Liabilities |
|
|
|
680 |
|
|
785 |
Total Long-Term Liabilities |
|
|
|
3,108 |
|
|
2,625 |
|
|
|
|
|
|
|
|
Total Liabilities |
|
|
|
31,083 |
|
|
30,780 |
|
|
|
|
|
|
|
|
Shareholders' Equity |
|
|
|
43,814 |
|
|
39,835 |
Total Liabilities and Shareholders'
Equity |
$ |
74,897 |
|
$ |
70,615 |
|
|
|
|
|
|
|
|
Non-GAAP Financial
MeasuresWhile Perceptron’s results under Generally
Accepted Accounting Principles in the United States of America
(“U.S. GAAP”) provide significant insight into our operations and
financial position, Perceptron’s management supplements its
analysis of the business using “Recurring Operating Income” and
“Recurring Net Income”. These are non-GAAP financial
measures. Management believes that these non-GAAP financial
measures, when taken together with the corresponding GAAP measures,
provides incremental insight into the underlying factors and trends
affecting our performance. However, it should be viewed as
supplemental data, rather than as a substitute or an alternative to
the comparable GAAP measure. The table below presents
reconciliations of each non-GAAP measure to Operating Income and
Net Income, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
PERCEPTRON, INC. |
Additional Information Regarding Special Items
Impacting |
Reported GAAP Financial Measures |
(Unaudited, In Thousands except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
|
|
|
December 31, |
|
December 31, |
|
|
|
|
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income, as reported |
|
|
$ |
455 |
|
$ |
3,257 |
|
$ |
2,000 |
|
$ |
1,278 |
|
|
|
|
|
|
|
|
|
|
|
|
Severance,
Impairment and Other Charges |
|
|
658 |
|
|
61 |
|
|
606 |
|
|
717 |
|
|
|
|
|
|
|
|
|
|
|
|
Excluding special items, |
|
|
|
|
|
|
|
|
|
Operating Income would have been |
|
$ |
1,113 |
|
$ |
3,318 |
|
$ |
2,606 |
|
$ |
1,995 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income, as reported |
|
$ |
366 |
|
$ |
2,524 |
|
$ |
1,924 |
|
$ |
169 |
|
|
|
|
|
|
|
|
|
Valuation
Allowance on DTA |
|
|
- |
|
|
- |
|
|
- |
|
|
511 |
|
|
|
|
|
|
|
|
|
Excluding special items, |
|
|
|
|
|
|
|
|
Net Income would have been |
|
$ |
366 |
|
$ |
2,524 |
|
$ |
1,924 |
|
$ |
680 |
|
|
|
|
|
Income Per Common Share
- |
|
|
|
|
|
Diluted, as reported |
|
$ |
0.04 |
|
$ |
0.27 |
|
$ |
0.20 |
|
$ |
0.02 |
|
|
|
|
|
Diluted
Income Per Share due to Valuation |
|
|
|
|
|
Allowance on DTA |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
0.05 |
|
|
|
|
|
Excluding special items, Diluted
Income |
|
|
|
|
|
per Share would have been |
|
$ |
0.04 |
|
$ |
0.27 |
|
$ |
0.20 |
|
$ |
0.07 |
|
|
|
|
|
Diluted Weighted Average Common
Shares |
|
|
|
|
|
Outstanding, as reported |
|
|
9,597 |
|
|
9,416 |
|
|
9,527 |
|
|
9,409 |
|
|
|
|
|
|
|
Contact:Investor Relationsinvestors@perceptron.com
Perceptron (NASDAQ:PRCP)
過去 株価チャート
から 6 2024 まで 7 2024
Perceptron (NASDAQ:PRCP)
過去 株価チャート
から 7 2023 まで 7 2024